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At synapses, cell adhesion molecules (CAMs) provide
the molecular framework for coordinating signaling
events across the synaptic cleft. Among synaptic
CAMs, the integrins, receptors for extracellular matrix
proteins and counterreceptors on adjacent cells, are
implicated in synapse maturation and plasticity and
memory formation. However, little is known about
the molecular mechanisms of integrin action at
central synapses. Here, we report that postsynaptic
b3 integrins control synaptic strength by regulating
AMPA receptors (AMPARs) in a subunit-specific
manner. Pharmacological perturbation targeting b3
integrins promotes endocytosis of GluR2-containing
AMPARs via Rap1 signaling, and expression of b3
integrins produces robust changes in the abundance
and composition of synaptic AMPARs without affect-
ingdendritic spinestructure. Importantly,homeostatic
synaptic scaling induced by activity deprivation ele-
vates surface expression of b3 integrins, and in turn,
b3 integrins are required for synaptic scaling. Our
findings demonstrate a key role for integrins in the
feedback regulation of excitatory synaptic strength.
INTRODUCTION
Activity-dependent synaptic plasticity is fundamental to the reg-
ulation and refinement of brain circuits. Despite our increasing
knowledge of the mechanisms by which activity modulates syn-
aptic efficacy, the underlying molecular basis remains to be fully
elucidated. It has long been recognized that synapses contain
a vast repertoire of cell adhesion molecules (CAMs). Once
thought of as components required only for the structural and
mechanical integrity of the connection, synaptic CAMs have
been increasingly recognized as key players in signaling events
regulating synapse function (Benson et al., 2000; Dityatev and
Schachner, 2003; Yamagata et al., 2003). Among CAMs, theintegrins, heterodimeric transmembrane receptors for extracel-
lular matrix proteins and counterreceptors on adjacent cells,
have received relatively little attention, especially in the central
nervous system (CNS). However, several observations point to
the integrins as potentially important regulators of synaptic
transmission and plasticity. Many integrin subunits are ex-
pressed in the CNS, where some, such as b3, are enriched at
synapses (Chan et al., 2003; Chavis and Westbrook, 2001; Pink-
staff et al., 1999; Shi and Ethell, 2006). Furthermore, the affinity of
integrins for their ligands is finely modulated in response to intra-
and extracellular signals; by interacting with the actin cytoskele-
ton and multiple intracellular signaling pathways, integrins can
transduce extracellular mechanical and chemical stimuli into
the cell (Hynes, 2002; Miranti and Brugge, 2002).
The Drosophila mutant Volado has provided the first persua-
sive evidence for a key role of integrins in the CNS. Ablation of
Volado, which encodes for two a integrins, impairs short-term
olfactory memory in flies (Grotewiel et al., 1998). Similarly, stud-
ies using mutant mice or specific inhibitors have shown that
some integrins, such as b1, are involved in the early stabilization
of long-term potentiation (LTP), a cellular model for learning and
memory (Chan et al., 2003; Staubli et al., 1998). Further studies
have however revealed that the function of integrins in synaptic
transmission is more complex and extends beyond a specific
requirement of integrins in LTP stabilization (Chan et al., 2006;
Chavis and Westbrook, 2001; Huang et al., 2006).
In the present study, we address the role of integrins in excit-
atory synaptic transmission and plasticity at a cellular and mo-
lecular level by making use of a simple circuit formed by cultured
hippocampal neurons. Specifically, we use acute pharmacolog-
ical disruption of integrin-ligand interactions, molecular manipu-
lations of integrin expression, and knockout mice to discriminate
between pre- and postsynaptic actions of integrins. We find that
postsynaptic b3 integrins rapidly adjust synaptic strength by
regulating GluR2-containing AMPAR endocytosis via a Rap1
signaling pathway and that perturbing b3 integrin expression
strongly affects synaptic AMPAR content. Remarkably, induc-
tion of homeostatic synaptic scaling by chronic blockade of net-
work activity increases surface expression of endogenous b3 in-
tegrins, and in turn, b3 integrins are required for synaptic scaling.Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc. 749
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b3 Integrins Regulate Excitatory Synaptic StrengthOur findings provide strong evidence that integrin signaling is
tightly coupled to excitatory synaptic transmission and required
for the homeostatic regulation of synaptic strength.
RESULTS
Rapid Integrin-Mediated Modulation of mEPSCs
To investigatewhether integrins regulateexcitatorysynaptic trans-
mission on a rapid timescale, we used peptides containing the
Arg-Gly-Asp (RGD) sequence found in the binding site of various
integrin ligands. Suchpeptidesdisrupt the interactionsofmany in-
tegrins, including those present in neurons (Ruoslahti, 1996). We
first examined the effects of acute bath application of RGD pep-
tides on miniature excitatory postsynaptic currents (mEPSCs),
which, in our recording conditions, represent the activation of syn-
aptic AMPARs in response to the spontaneous release of neuro-
transmitter. A synthetic RGD peptide (GRGDSP) or the disintegrin
echistatin, an RGD peptide from viper venom that targets b3- and
b1-containing integrins with high affinity (Pfaff et al., 1994), reliably
and reversibly reduced mEPSC amplitude by 20% in all cells
tested (Figures 1A and 1B; mEPSC amplitude after echistatin
Figure 1. RGD Peptides Reduce mEPSC
Amplitude
(A) Overlay of mEPSC traces recorded from a hip-
pocampal pyramidal neuron of rat primary cultures
over a 5 min control period (), the last 5 min of
a 10 min bath application of echistatin (100 nM),
and the last 5 min of a 10 min wash. Gray traces
are aligned original mEPSCs, and black traces
represent the population average.
(B) Cumulative distribution plot of mEPSC ampli-
tudes from the experiment shown in (A) (p < 0.01,
control versus echistatin).
(C) Average mEPSC amplitude during control and
echistatin application shown pairwise for each cell
(p < 0.05 for each pair).
(D) The reduction in mEPSC amplitude is maximal
after 5 min bath application of echistatin (n = 13).
Each data point represents the mean amplitude
over 100 s intervals normalized to baseline (**p <
0.01 relative to baseline).
(E) Summary of the peptide effects onmEPSC am-
plitude. Mean amplitudes from the last 5 min of
a 10 min application are plotted relative to 5 min
baseline for untreated control cells (n = 4) and
echistatin (n = 6), for the control GRGESP peptide
(RGE, 200 mM; n = 5) and GRGDSP (RGD, 200 mM;
n = 5) (*p < 0.04).
Error bars indicate SEM.
wash-out: 1.01 ± 0.01 of baseline [n = 3]).
The decrease in quantal size developed
gradually, being maximal after 5 min (Fig-
ure 1D), and was specific as the control
peptide (GRGESP) was ineffective (Fig-
ure 1E). Neither the initial mEPSC ampli-
tude nor recording conditions promoting
low or high release probability affected
the efficacy of the peptides (Figure 1C; av-
erage mEPSC amplitude upon echistatin application: 0.82 ± 0.05
of baseline in both 2.2 mM Ca2+/1.5 mM Mg2+ [n = 6] and 5 mM
Ca2+/0.6 mM Mg2+ [n = 7]). Moreover, the decrease in quantal
size was not accompanied by changes in mEPSC waveform
(see Figure S1B available online). We also examined the effects
on mEPSC frequency. Whereas the peptides had no effect on
the overall mEPSC frequency, a transient burst ofmEPSCs lasting
a few seconds was observed after a variable time interval in many
but not all cells tested (Figure S1A; 11 out of 13 for echistatin and 4
outof5 forGRGDSP). Thehighlydistinct timecourseof thechange
in mEPSC frequency compared to that of mEPSC amplitude and
the differences in their occurrence and pharmacological profiles
(L.A.C. andY.G., unpublisheddata) suggested that the twoeffects
arose from distinct mechanisms. We next aimed to clarify the
molecular mechanisms by which disrupting integrin interactions
alters the amplitude of synaptic AMPAR currents.
Echistatin-Induced Reduction in Quantal Size Requires
Elevation of Intracellular Ca2+
We first examined the involvement of the actin cytoskeleton, with
which integrins dynamically interact via linker proteins such as750 Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc.
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b3 Integrins Regulate Excitatory Synaptic Strengthtalin and a-actinin (Liu et al., 2000). Depolymerizing actin
filaments with latrunculin A increased the mEPSC frequency
without affecting its amplitude (Figure 2B and data not shown)
as previously reported (Morales et al., 2000). Moreover, latruncu-
lin A did not prevent the echistatin-induced decrease in quantal
size (Figures 2A–2C), thus ruling out a major contribution of actin
filaments in the integrin-mediated modulation of synaptic
AMPAR currents. In contrast, buffering intracellular Ca2+ with
BAPTA-AM or loading BAPTA into the postsynaptic neuron via
the patch-pipette completely blocked the reduction in mEPSC
amplitude (Figures 2A–2C). The modulation of quantal size by
integrins, therefore, requires an elevation of intracellular Ca2+
specifically in the postsynaptic cell.
We next tested the role of NMDA receptors (NMDARs), which
are Ca2+ permeable and can be activated by a single quantum of
Figure 2. Echistatin-Mediated Reduction in
mEPSC Amplitude Requires Elevation of
Intracellular Ca2+
(A) mEPSC population averages before () and af-
ter echistatin application (100 nM), and (B) cumu-
lative distributions of mEPSC amplitudes from
representative neurons where echistatin was ap-
plied at least 5min after treatments with latrunculin
A (LatA, top) or ifenprodil (bottom) or applied in the
presence of BAPTA in the intracellular solution
(BAPTApost, middle).
(C) Summary of the echistatin effects on mEPSC
amplitude in the presence of blockers or Ca2+ che-
lators: LatA (20 mM; *p = 0.04 relative to baseline,
n = 4), D-APV (50 mM; n = 6), ifenprodil (3 mM; n =
6), BAPTA-AM (100 mM, n = 6), BAPTApost (37.5–
50 mM, n = 6). Echistatin does not reduce mEPSC
amplitude in the presence of Ca2+ chelators or
NMDAR blockers.
(D) Traces of evoked autaptic AMPAR and
NMDAR synaptic currents from a representative
experiment before (baseline) and after echistatin
application (100 nM). The unclamped Na+ spikes
have been blanked for clarity.
(E) Time courses of the echistatin effect on peak
AMPAR current (left, n = 5, p = 0.03) and on
NMDAR charge transfer (right, n = 6, p = 0.53;
open triangles: responses used to evaluate statis-
tical significance). Echistatin selectively reduces
the AMPAR current.
Error bars indicate SEM.
neurotransmitter (Gomperts et al., 1998).
Blocking NMDARs with either D-APV or
the selective NR2B antagonist ifenprodil
had no effect on mEPSC amplitude
(Figure 2B) but prevented the decrease
in quantal size induced by echistatin (Fig-
ures 2A–2C; p = 0.0002 versus control
without NMDAR antagonists [n = 9]).
Hence, acute modulation of synaptic
AMPAR currents by integrins requires
Ca2+ influx mediated by NMDARs.
The observed requirement for
NMDARs raised the possibility that the re-
duction in AMPAR currents was a secondary effect of a direct ac-
tion of integrins onNMDARs. Chronic incubation of hippocampal
cultures with echistatin, for example, has been shown to affect
NMDARs (Chavis and Westbrook, 2001). Therefore, to monitor
the acute effects of echistatin on NMDAR currents, we elicited
dual AMPAR and NMDAR synaptic currents from autapses in
nominally 0 Mg2+. Evoked AMPAR currents were depressed by
echistatin to a similar extent and with a similar time course as
quantal AMPAR events. In contrast, the NMDAR component
showed no change (Figures 2D and 2E). In addition, NMDAR cur-
rents evoked by local NMDA application (50 mM, 3 s long puffs)
were also unaffected by echistatin (100 nM; effect on charge
transfer: 1.04 ± 0.01 of baseline after 5–7 min [n = 3, p = 0.37]).
Thus, although basal NMDAR activity is necessary for the integ-
rin-mediated regulation of synaptic AMPAR currents, acuteNeuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc. 751
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selective effect of echistatin on one of the two glutamatergic
synaptic currents also excludes the presynaptic release machin-
ery as the cause of reduced quantal size, as changes in neuro-
transmitter release would affect both AMPAR and NMDAR
components.
While monitoring the effects of synthetic RGD peptides in par-
allel experiments, we found that GRGDSP (200–500 mM) rapidly
and potently increased NMDAR currents, but only when the
NMDAR coagonist glycine was excluded from the extracellular
recording solution; no effect was seen in the presence of saturat-
ing concentrations of glycine (20 mM; Figures S2C–S2E). In
contrast, the more potent and specific peptide echistatin (100–
300 nM) had no effect on NMDAR currents irrespective of the
presence or absence of glycine (Figures 2D, 2E, and S2D). The
EC50 of the glycine-binding site of the NMDAR for glycine is
less than 1 mM (Matsui et al., 1995). Therefore, in the absence
of glycine, short RGD peptides, at the high concentrations
used,may directly potentiate NMDARcurrents either by interact-
ing with the glycine-binding site or because of glycine impurities
in the peptide preparation. To avoid such complications, the
effects of synthetic RGD peptides were always compared to
those of echistatin.
The lack of involvement of actin filaments on integrin modula-
tion of synaptic AMPARs argues against the contribution of ma-
jor structural alterations. A previous study using synthetic RGD
peptides, however, reported of a change in dendritic protrusions
(Shi and Ethell, 2006). The reduced quantal size could, therefore,
result from postsynaptic structural modifications. To examine
such a possibility, we carried out time-lapse video recording of
neurons expressing YFP-actin as a marker of dendrite and spine
morphology. In agreement with previous studies (Shi and Ethell,
2006), high concentrations of short synthetic RGD peptides
elongated dendritic protrusions and increased their mobility after
30 min of application; in contrast, echistatin treatment did not
produce such changes (Figures S2A and S2B; dendritic protru-
sion length relative to baseline after 30 min with GRGDSP:
+15.6% ± 2.3%, p = 0.002; with GRADSP: 3.1% ± 0.4%, p =
0.33; with echistatin:1.8% ± 0.2%, p = 0.29; 33–63 protrusions
from three cells each). The difference between the two RGDpep-
tides could reflect their differential effect on NMDAR currents.
Importantly, neither echistatin nor the synthetic RGD peptide
produced a discernable structural change during the initial
10 min of application when the reduction in synaptic AMPAR
currents was observed. These results suggest that the integrin-
dependent reduction in mEPSC amplitude is not a secondary
consequence of structural changes.
Integrins Regulate GluR2 Endocytosis
One of the major mechanisms for regulating synaptic strength
involves changes in AMPAR trafficking. We therefore tested
the possibility that disrupting integrin interactions reduced quan-
tal size by affecting AMPAR endocytosis. Loading neurons with
GTPgS via the patch pipette to impair all GTP hydrolysis-depen-
dent activities, including that of dynamin, prevented the reduc-
tion in mEPSC amplitude induced by echistatin (Figure 3B). To
selectively impair dynamin-dependent endocytosis, we loaded
neurons with the D15 peptide, which interferes with the binding752 Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc.of dynamin to amphiphysin (Luscher et al., 1999). As with
GTPgS, the D15 peptide prevented the echistatin-induced re-
duction in mEPSC amplitude, whereas a scrambled version of
the peptide (S15) did not (Figures 3A and 3B). The time course
for mEPSC amplitudes in the presence of D15 was the same
with or without echistatin (Figure 3B), thus excluding the possibil-
ity that a potential effect of echistatin was masked by a concom-
itant run up of the currents. Echistatin therefore reduces mEPSC
amplitudes by affecting the exo-endocytic cycling of AMPARs.
To directly test whether disrupting integrin interactions has an
effect onAMPARendocytosis,weusedanantibody-feeding fluo-
rescence assay to quantify the degree of internalization of the en-
dogenous AMPAR subunits GluR1 and GluR2. Acute treatment
with echistatin increased the internalization of GluR2 by 25%
but did not affect that of GluR1 (Figures 3Cand 3D). The synthetic
RGD peptide but not the control peptide increased GluR2 inter-
nalization to a similar extent as echistatin (data not shown). We
further investigated the specificity of echistatin for GluR2 by
artificially changing the subunit composition of AMPARs by over-
expressing eitherGluR1orGluR2. Echistatinwas no longer effec-
tive in reducingmEPSCamplitude inGluR1-overexpressingcells,
whereas GluR2-overexpressing neurons remained sensitive to
echistatin (Figure S3). Taken together, these findings indicate
that integrins affect quantal size by specifically regulating the
endocytosis of GluR2-containing AMPARs.
Rap1 in Integrin Modulation of Synaptic
AMPAR Currents
The small GTPase Rap1 is implicated in several aspects of integ-
rin-mediated signaling in nonneuronal cells (Bos et al., 2001;
Miranti and Brugge, 2002), and, in neurons, Rap1 is involved in
regulating synaptic AMPAR content and trafficking (Fu et al.,
2007; Xie et al., 2005; Zhu et al., 2002). Therefore, we asked
whether the echistatin-dependent reduction in AMPAR currents
by endocytic loss of GluR2 involved Rap1 activation. First, we
examined whether Rap1 activity affected the surface expression
of AMPAR subunits in our system. Consistent with previous re-
ports (Fu et al., 2007; Zhu et al., 2002), inhibiting Rap1 activity
by overexpressing a dominant-negative Rap1 (Rap1DN) signifi-
cantly increased surface levels of endogenous GluR2 but not
GluR1 in hippocampal pyramidal neurons (Figure S4). We next
asked whether echistatin could activate Rap1 under conditions
in which it induced GluR2 endocytosis. Following a 10 min incu-
bation with echistatin, we found strong activation of endogenous
Rap1 (Figure 4A). Thus, Rap1 activation is a potential signaling
mechanism by which echistatin triggers the internalization of
GluR2. To test whether the echistatin-induced decrease in quan-
tal size requires Rap1 activation, we recorded mEPSCs from
neurons overexpressing Rap1DN. Despite the increased GluR2
surface expression, echistatin was ineffective in reducing
mEPSC amplitude (Figures 4B and 4C), and the lack of effect
was not due to altered b3 surface levels, which remained un-
changed (Figure S4). Rap2 is the most homologous small
GTPase to Rap1 and, like Rap1, is present at excitatory synap-
ses where it has also been implicated in AMPAR trafficking (Fu
et al., 2007; Reuther and Der, 2000; Zhu et al., 2005). However,
overexpression of Rap2 carrying a homologous mutation to
that of Rap1DN did not impair the echistatin-mediated reduction
Neuron
b3 Integrins Regulate Excitatory Synaptic Strengthin quantal size (Figures 4B and 4C), arguing for a specific involve-
ment of Rap1. Most likely, therefore, disrupting integrin interac-
tions leads to an activation of Rap1, which in turn, is required for
the reduction in synaptic AMPAR currents.
Postsynaptic b3 Integrins Control Synaptic
AMPAR Currents
RGD-containing peptides pose some limitations in assessing the
role of integrins. First, they target several integrin heterodimers,
and therefore they alone cannot be used to identify the specific
subunits involved in the biological response under investigation.
Second, they do not discriminate between intracellular (cis) and
cell-cell or cell-substrate (trans) actions of integrins when multi-
cellular structures are involved. Thus, in order to determine the
cellular location and subtypes of integrins involved in regulating
glutamatergic quantal responses, we focused on b1 and b3 in-
Figure 3. Integrins Regulate GluR2
Endocytosis
(A) Neurons were loaded with D15 (left) or a scram-
bled S15 peptide (right) for at least 10 min prior to
the baseline period. mEPSC population averages
are from representative neurons during 5 min
baseline (–) and the last 5 min of a 10 min applica-
tion of echistatin (100 nM).
(B) Time course of mEPSC amplitudes from neu-
rons loaded with GTPgS (0.5 mM; n = 6) or D15
or S15 peptides (0.25–2 mM; D15, n = 5; D15 +
echistatin, n = 6; S15 + echistatin, n = 6). Each
data point represents the average mEPSC ampli-
tude over 100 s interval normalized to the first
100 s (*p = 0.03, **p < 0.01). Echistatin does not re-
duce mEPSC amplitudes under conditions that
block endocytosis.
(C) Internalization assay for endogenous GluR1
(left) and GluR2 (right) subunits. Surface (top) ver-
sus internalized fractions (bottom) from represen-
tative 10 min mock- (untreated) and echistatin-
treated neurons (300 nM) are shown. Scale bars,
30 and 10 mm.
(D) Summary of GluR1 (n = 21 images each from
four independent cultures) and GluR2 (n = 36 im-
ages each from five independent cultures) inter-
nalization assay. Internalized fraction indicates:
(mean intensitysurface)/(mean intensitysurface +
mean intensityinternalized). ***p = 0.00002. Echistatin
specifically increases GluR2 endocytosis.
Error bars indicate SEM.
tegrins, which are targeted by echistatin.
We used either full-length wild-type b1 or
b3 integrins (WTb1 and WTb3, respec-
tively) or truncated forms of the two sub-
units in which the entire extracellular
domain was replaced with EGFP (CTb1
and CTb3, respectively); previous studies
have established that these chimeras
localize with the respective endogenous
integrins, and when expressed at high
levels, act as specific dominant-negative
inhibitors of integrin function (LaFlamme
et al., 1994; Smilenov et al., 1999). We transfected our cultures
with these constructs after the initial wave of synaptogenesis
and examined neurons after 2 days of expression. WTb3,
CTb3, and CTb1 showed punctate surface expression along
the processes without an appreciable effect on the overall cell
morphology and passive membrane properties (Figures S5A
andS5E). In contrast,WTb1was toxic for neurons under a variety
of conditions and could not be used.
By taking advantage of the low transfection efficiency in pri-
mary neuronal cultures, we restricted mEPSC recordings to
transfected neurons surrounded only by nontransfected cells.
In this configuration, the patched neuron received synaptic in-
puts mostly from nontransfected cells, and we could consider
the effects of postsynaptic expression of the constructs. Expres-
sion of b3 integrins resulted in a robust and bidirectional change
in mEPSC amplitude relative to control cells: WTb3 producedNeuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc. 753
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27.9 ± 3.0 pA for controls [n = 22, p = 0.001]), whereas CTb3
produced a large decrease (mean: 18.9 ± 1.0 pA for CTb3
[n = 26] versus 27.9 ± 3.0 for controls [n = 22, p = 0.002]) (Fig-
ures 5A–5C). mEPSC waveform, however, remained unaltered
(Figure S5C). Cells expressing CTb3 showed a tendency toward
lower mEPSC frequency, probably reflecting a larger number of
mEPSCs falling below the detection threshold (Figure S5D). The
effects of exogenous b3 integrins on quantal size were not influ-
enced by chronic blockade of NMDAR activity (Figure S5F).
Compared with the large changes induced by the expression
of b3 constructs, CTb1 had no effect on mEPSC amplitude
(mean: 31.3 ± 5.4 pA for CTb1 [n = 8] versus 29.1 ± 7.0 pA
for controls [n = 8, p = 0.81]) (Figure 5C), despite being expressed
at similar levels as CTb3 (Figure S5A and S5B).
Whereas acute application of RGD peptides did not induce
structural changes over a timescale of minutes, expression of
integrin constructs over a 2 day period could potentially affect
spine morphology, especially given their large effects on quantal
size. However, extensive morphological analyses failed to reveal
significant alterations in spine density, length, or width in neurons
expressingWTb3,CTb3, orCTb1 relative to controlGFPneurons.
Moreover, the proportion of mushroom, thin, and stubby spines
as well as filopodia also remained unchanged (Figures 5D and
5E). These results suggest that b3 integrin-dependent changes
Figure 4. Echistatin-Mediated Activation of Rap1 Is Required for
mEPSC Amplitude Decrease
(A) Pull-down with GST-RalGDS-RBD from mock- (Untreat) and echistatin-
treated (Echi, 300 nM, 10min at 37C) culture lysates (500 mg each) reveals ac-
tivation of endogenous Rap1 by echistatin (top right). Comparable amounts of
Rap1 were detected from the respective lysates (20 mg per lane, bottom right).
Top left, lysates were treated with GDP (1 mM; negative control) or GTPgS
(0.1 mM; positive control). Exposure times are different for the three panels
shown. Similar results were obtained in four independent experiments.
(B) mEPSC population averages from representative neurons expressing
Rap1DN (top) or Rap2DN (bottom), before (–) and after echistatin application
(100 nM). Basal mEPSC amplitude is not significantly different between
Rap1DN- and Rap2DN-transfected neurons (30.6 ± 3.1 pA versus 27.5 ±
2.2 pA, respectively; n = 6–8, p = 0.44).
(C) Summary of experiments as in (B) shown pairwise for individual cells and as
bar graph for the average cell population (**p = 0.002). Echistatin does not re-
duce mEPSC amplitudes under conditions that prevent Rap1 activation.
Error bars indicate SEM.754 Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc.in quantal size are not accounted for by alterations in synapse
morphology and that postsynaptic b3 integrins bidirectionally
regulate AMPAR currents independently of structural changes.
Control of AMPAR Subunit Composition by b3 Integrins
Weused four complementary approaches to investigatewhether
the effects of b3 integrins on quantal size could be explained by
changes in AMPAR subunit composition. First, we tested the
efficacy of philanthotoxin-433 (PhTx), a specific blocker of
GluR2-lacking AMPARs, onmEPSC amplitudes. PhTx had no ef-
fect in control neurons as reported previously (Thiagarajan et al.,
2005) nor in WTb3 cells, but it decreased mEPSC amplitude in
CTb3 neurons, which already displayed severely reduced synap-
tic currents (Figures 6Aand6D). This selective effect of PhTx sug-
gested that GluR2-containing AMPARs predominated in control
and WTb3 cells and that CTb3 expression decreased quantal
size by preferentially depleting GluR2-containing AMPARs.
Second, we examined by immunofluorescence labeling
whether the expression of b3 integrins affected the surface level
and distribution of endogenous GluR1 and GluR2 subunits (Fig-
ure 6B). In control neurons, both GluR1 and GluR2 signals were
punctate, although some GluR2 showed diffuse expression
along the dendrites. In WTb3 neurons, the diffuse GluR2 signal
was less apparent, and instead, surface GluR2 fluorescence
was highly punctate and bright. The total dendritic surface fluo-
rescence for GluR2 and GluR1, however, was not measurably
altered relative to controls (Figure 6E). In CTb3 neurons, both
fluorescence signals were generally weak, with the GluR2 signal
being significantly reduced relative to control cells (Figures 6B
and 6E), and the ratio of surface GluR2 to GluR1 was also de-
creased (1.07 ± 0.10 in control cells versus 0.81 ± 0.06 in CTb3
neurons; p = 0.03). The specific reduction in the GluR2 to
GluR1 ratio in CTb3 neurons is in line with the PhTx sensitivity,
which was also exclusive to CTb3 neurons.
Third, we recorded agonist-evoked AMPAR currents and
studied their degree of rectification, which is highly sensitive to
GluR2 content. WTb3 neurons showedmore outwardly rectifying
current-voltage (I-V) relationships than controls, indicating en-
richment in GluR2. In contrast, CTb3 neurons exhibited inwardly
rectifying I-V relationships, denoting paucity of GluR2 subunits
(Figures 6C and 6F).
Last, to selectively target GluR2-containing AMPARs, we took
advantage of a peptide, pep2m, containing the NSF-binding
sequence of GluR2. This peptide, when intracellularly perfused,
compromises GluR2 surface delivery and thereby reduces cur-
rents mediated by GluR2-containing AMPARs (Luscher et al.,
1999; Song et al., 1998). We found that intracellular dialysis of
pep2m significantly decreased mEPSC amplitudes only in neu-
rons overexpressing WTb3 (Figure 6G). The reduction was spe-
cific to pep2m, because a homologous control peptide, pep4c,
from GluR4, which is unable to bind NSF (Nishimune et al.,
1998), had no effect. In agreement with a previous study that
used concentrations of pep2m similar to ours (Noel et al.,
1999), mEPSC amplitudes were not significantly reduced by
pep2m in nontransfected cells. Because pep2m inhibits evoked
EPSCs more potently than mEPSCs (Luscher et al., 1999; Nishi-
mune et al., 1998), possibly because of its activity-dependent
actions (Luscher et al., 1999), we confirmed the effectiveness
Neuron
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EPSCs declined in neurons loaded with pep2m but remained
stable with pep4c (Figure S6), indicating that pep2m was active
in our recording conditions.
Collectively, these results support a model in which b3 integ-
rins increase quantal size by effectively stabilizing synaptic
GluR2-containing AMPARs, whereas loss of contact with b3
extracellular ligands as a consequence of CTb3 expression or
application of RGD peptides depletes synapses preferentially
of GluR2 subunits.
Postsynaptic b3 Integrins Mediate
the Echistatin-Induced Reduction in Quantal Size
To further investigate the regulation of synaptic AMPARs by b3
integrins, we next made use of b3 integrin-deficient mice, which
Figure 5. Postsynaptic Expression of b3
Integrins Alters mEPSC Amplitude
(A) Sample mEPSCs and (B) histograms of mEPSC
amplitudes from representative neurons overex-
pressing WTb3 and mRFP (WTb3, top), mRFP
(control, middle), or CTb3 and mRFP (CTb3,
bottom).
(C) Summary of group data from experiments as in
(A). WTb3 increases and CTb3 decreases mEPSC
amplitudes.
(D) Images of dendrites from pyramidal neurons
overexpressing WTb3 and GFP (WTb3, top), GFP
(control, middle), or CTb3 and GFP (CTb3, bot-
tom). Synapsin (red) was used as a presynaptic
marker. Scale bar, 4 mm.
(E) Summary of spine measurements. None of the
differences were statistically significant (n = 19
cells for control and WTb3; n = 20 for CTb3 and
CTb1).
Error bars indicate SEM.
were viable and fertile (Hodivala-Dilke
et al., 1999). Hippocampal pyramidal
neurons from homozygous (b3/) and
heterozygous (b3+/) pups were plated
on wild-type glial cells. They grew nor-
mally in culture and developed morphol-
ogies comparable to neurons cultured
from wild-type littermates (b3+/+). The
surface level and distribution of GluR1
and GluR2 subunits were not detectably
different in b3/, b3+/, and b3+/+ neu-
rons (Figure 7A). Furthermore, patch-
clamp recordings revealed no significant
differences in passive membrane proper-
ties of b3/ and b3+/ mutant neurons
compared to wild-type cells (Figure S7C).
Similarly, quantal excitatory synaptic
transmission was normal in b3/ and
b3+/ cultures relative to b3+/+ cultures:
no significant changes were detected
for mEPSC amplitude, frequency, and
waveform (Figures 7B, S7A, and S7B).
The lack of an apparent phenotype suggests that b3 integrins
are dispensable for the development and basic function of syn-
apses. However, if b3 integrins are specifically involved in regu-
lating synaptic AMPARs, then echistatin should be ineffective in
modifying quantal size in neurons lacking b3 integrins. Indeed,
echistatin application had no effect on mEPSC amplitude in
b3/ neurons, whereas it reduced quantal size in b3+/ neurons
as effectively as in rat cultures (Figures 7C and 7D; cf. Figure 1).
Thus, b3 integrins are necessary for the echistatin-induced
reduction in quantal size. To confirm the specific involvement
of postsynaptic b3 integrins, we tested whether postsynaptic ex-
pression of WTb3 in b3/ neurons for 2 days could rescue the
effect of echistatin. As shown in Figure 7E, in WTb3-expressing
neurons from b3 integrin-deficient cultures, echistatin reduced
mEPSC amplitude (0.76 ± 0.07 of baseline, n = 6) to an extentNeuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc. 755
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AMPAR Subunit Composition
(A) mEPSC population averages from representa-
tive neurons overexpressing WTb3 and mRFP
(WTb3, left), mRFP (Control, middle), or CTb3
and mRFP (CTb3, right), during 5 min baseline (–)
and the last 5 min of a 10 min application of the
GluR2-lacking AMPAR blocker PhTx (10 mM).
(B) Representative images of GluR1 (red) and
GluR2 (green) surface labeling for neurons trans-
fected withWTb3 and GFP (WTb3, left), GFP (Con-
trol, middle), or CTb3 and GFP (CTb3, right). GluR1
and GluR2 were stained with Cy3- and Cy5-conju-
gated secondary antibodies, respectively. GFP
fluorescence is not shown. Scale bars, 30 and
5 mm.
(C) Agonist-evoked AMPAR I-V relationships from
untransfected neurons (middle) and neurons over-
expressing WTb3 (left) or CTb3 (right). Recordings
were performed in outside-out somatic patches in
response to a voltage ramp from +60 to 90 mV
delivered over 3 s. Currents were elicited by bath
application of kainate (100 mM) and blocked by
SYM 2206 (Sym; 25–50 mM).
(D) Summary of the effects of PhTx on mEPSC
amplitudes. The reduction of mEPSC amplitudes
is shown relative to baseline (n = 6 for each condi-
tion, **p = 0.01 relative to baseline). Only mEPSCs
recorded from CTb3-expressing neurons are
reduced by PhTx.
(E) Summary of the GluR1 and GluR2 surface
levels for experiments as in (B). Fluorescence in-
tensity was quantified on the full dendritic arbor
(n = 27, 23, and 26 images for WTb3, control,
and CTb3, respectively; *p = 0.02 relative to
control).
(F) Summary of I-V rectification indices (–I-60/I+40)
from recordings as in (C) (WTb3, n = 5; control,
n = 8; CTb3, n = 6; *p = 0.04 relative to control).
WTb3 expression decreases and CTb3 expres-
sion increases the rectification of agonist-evoked
AMPAR currents.
(G) Time course of mEPSC amplitudes from
untransfected neurons (Control), and neurons
overexpressing WTb3 or CTb3, using intracellular
solutions supplemented with pep2m or pep4c
peptides (150 mM; Control + pep2m, n = 4; CTb3 +
pep2m, n = 6; WTb3 + pep2m, n = 6; WTb3 +
pep4c, n = 4). Each data point represents the aver-
age mEPSC amplitude over 100 s interval normal-
ized to the first 100 s (*p = 0.02 and **p < 0.007).
Only mEPSCs recorded from WTb3 neurons are
decreased by pep2m.
Error bars indicate SEM.comparable to control mouse b3+/ cultures (0.82 ± 0.03 of
baseline, n = 5; p = 0.40 compared to rescue) and rat cultures
(0.82 ± 0.05 of baseline, n = 13, p = 0.42 compared to rescue).
Moreover, postsynaptic expression of the dominant-negative
CTb3 in rat cultures was sufficient to prevent the echistatin-
dependent reduction in mEPSC amplitude (Figure S8). Taken
together, these experiments indicate that postsynaptic b3 integ-
rins are necessary and sufficient for the echistatin-induced
downregulation of synaptic AMPAR currents.756 Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc.Postsynaptic b3 Integrins Are Required
for Homeostatic Synaptic Scaling
Thus far our findings identify the contribution of postsynaptic b3
integrins in regulating synaptic strength and AMPAR subunit
composition. We next asked whether b3 integrins could play
a role in activity-dependent changes in synaptic strength at ma-
ture synapses. Such a function for this particular integrin subtype
has not been explored to date. Notably, homeostatic synaptic
plasticity induced by chronic modifications of neuronal network
Neuron
b3 Integrins Regulate Excitatory Synaptic Strengthactivity scales quantal size by changing the abundance and com-
positionofAMPARs (O’Brienet al., 1998;Suttonet al., 2006; Thia-
garajan et al., 2005; Turrigiano et al., 1998;Wierenga et al., 2005).
However, the underlying molecular mechanisms are still poorly
understood. In order to determine whether integrins are involved
in synaptic scaling, we first examined whether the surface ex-
pression of endogenous integrins is affected by chronic changes
in neuronal network activity. Live antibody labeling revealed sig-
nificant changes in the level of b3 but not b1 integrins in response
to chronic treatmentswith bicuculline or tetrodotoxin (TTX) to en-
hance or reduce network activity, respectively. TTX was espe-
cially effective in increasing b3 surface levels (Figures 8A and
8B). The effect developedgradually over 24 hr (Figure 8C)without
a detectable change in total protein expression (Figure 8D).
Figure 7. Postsynaptic b3 IntegrinsMediate
the Echistatin-Induced Reduction in
mEPSC Amplitude
(A) Left, representative images of GluR1 (red) and
GluR2 (green) surface labeling for hippocampal
pyramidal neurons from b3/ and b3+/ mouse
primary cultures. Scale bar, 30 mm. Right, sum-
mary of the surface levels of GluR1 and GluR2
(n = 29, 24, and 16 images for b3/, b3+/, and
b3+/+, respectively).
(B) Left, sample traces of mEPSC recordings from
hippocampal pyramidal neurons of b3/ (top) and
b3+/ (bottom) mouse primary cultures. Right,
summary of group data from experiments as on
the left but also including recordings from b3+/+
mouse cultures (average amplitude: 30.4 ± 3.8
pA for b3/ [n = 21], 28.7 ± 1.8 for b3+/ [n =
16], and 28.4 ± 2.3 pA for b3+/+ [n = 13]). None
of the differences were statistically significant.
(C) Left, mEPSC population averages of a hippo-
campal pyramidal neuron from b3/ mouse
primary cultures before (left trace) and after (right
trace) echistatin application (100 nM). Middle,
cumulative distribution of mEPSC amplitudes for
the experiment shown on the left. Right, summary
for individual cells shown pairwise and for the
average cell population shown as bar graph.
(D) As in (C) but for hippocampal pyramidal
neurons from b3+/ mouse primary cultures.
**p = 0.009.
(E) As in (C) but for b3/ hippocampal pyramidal
neurons transfected with WT b3. **p = 0.01.
Error bars indicate SEM.
Next, we wanted to gain an insight into
how chronic changes in network activity
modified surface expression of b3 integ-
rins. Recently, synaptic scaling induced
by TTX has been shown to require the
progressive accumulation in the extracel-
lular medium of tumor necrosis factor-a
(TNFa) derived from glia (Stellwagen and
Malenka, 2006). Interestingly, exposure
to TNFa is known to increase aVb3 integ-
rin levels in nonneuronal cells (Gao et al.,
2002; Hynes, 2002). We therefore examined whether TNFa
affected surface expression of b3 integrins in hippocampal pyra-
midal neurons. Acute treatment with TNFa, within 20 min,
increased b3 levels nearly as much as chronic incubation with
TTX (23% versus 28% increase, Figures 8E and 8F), and
the enhancement was maintained at least up to 12 hr of TNFa
treatment. Therefore, TNFa is a plausible candidate for mediat-
ing the observed increase in surface b3 integrins upon activity
deprivation by TTX.
If the increase in b3 is instrumental in the homeostatic regula-
tion of synaptic AMPAR currents, then TTX-induced synaptic
scaling should be blocked in neurons overexpressing domi-
nant-negative CTb3. Also, TTX might be ineffective in triggering
additional quantal scaling in WTb3 cells with elevated surfaceNeuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc. 757
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Required for Synaptic Scaling
(A) Surface labeling of endogenous b3 (top) and b1
(bottom) integrins for untreated (middle) and bicu-
culline- (20 mM, 48 hr; left) or TTX-treated (1 mM,
48 hr; right) hippocampal cultures. Scale bars, 30
and 10 mm.
(B) Summary of the effects of 48 hr bicuculline or
TTX treatments on the surface expression of
GluR2 and b1 and b3 integrins (bicuculline, b3,
n = 28 images; TTX, b3, n = 65; bicuculline, b1,
n = 30; TTX, b1, n = 30; bicuculline, GluR2, n =
16; TTX, GluR2, n = 18; *p = 0.03, **p = 0.006,
***p < 0.0002 relative to untreated controls).
Chronic changes in neuronal network activity alter
surface expression of b3 integrins and GluR2 but
not b1 integrins.
(C) b3 integrin surface expression in response to
TTX treatments of different durations (6 hr, n =
25; 12 hr, n = 24; 24 hr, n = 26; 48 hr, n = 30;
*p = 0.05, **p = 0.004, ***p < 0.00001 relative to
untreated controls).
(D)Western blot of protein extracts (20 mg per lane)
from untreated (–) and TTX-treated (1 mM, 48 hr)
sister cortical cultures reveals no changes in the
total amount of b3 integrins. The same membrane
was reprobed with an anti-actin antibody. Bar
graphs indicate quantification of three indepen-
dent experiments.
(E) Surface labeling of b3 integrins for untreated
(top) and TNFa-treated (0.1 mg/ml, 20 min; bottom)
hippocampal cultures. Surface b3 levels are higher
in TNFa-treated cultures. Scale bar, 10 mm.
(F) Summary of the increase in b3 and GluR2 sur-
face expression induced by TNFa (n = 27 each
for b3 and n = 39 each for GluR2; **p = 0.002,
***p < 0.0004 relative to untreated controls).
(G) Summary of mEPSC amplitudes from hippo-
campal pyramidal neurons of b3/ and b3+/
mouse primary cultures incubated with (red) or
without (black) TTX (1 mM, 48 hr; b3/, n = 21;
b3/ + TTX, n = 21; b3+/, n = 16; b3+/ + TTX,
n = 18; p = 0.008 between b3+/ and b3+/ +
TTX). Insets, mEPSC population averages from
representative experiments. Scale bars, 4 ms
and 10 pA.
(H) As in (G) but for CA1 pyramidal neurons of
mouse hippocampal slice cultures (b3/, n = 18;
b3/ + TTX, n = 19; b3+/, n = 18; b3+/ + TTX,
n = 18; p = 0.000003 between b3+/ and b3+/ +
TTX). Scale bars for insets, 8 ms and 5 pA.
Error bars indicate SEM.b3 integrins. As summarized in Figure S9A, chronic TTX treat-
ment scaled mEPSCs in control neurons but not in CTb3 cells,
suggesting that b3 integrins are required for synaptic scaling.
Moreover, TTX did not further increase mEPSC amplitude in
WTb3 neurons. This result is consistent with the effects of TTX
being occluded by WTb3 expression, suggestive of shared
mechanisms involving upregulation of surface b3. In further
support, exogenous expression of b3 integrin constructs scaled
mEPSCs multiplicatively (Figure S9B), which is a hallmark
feature of homeostatic synaptic plasticity (Turrigiano et al.,
1998).758 Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc.Our results thus far are consistent with TTX-induced synaptic
scalingbeingdependentonanupregulationofpostsynapticb3 in-
tegrins. To directly assess the requirement of b3 integrins for this
formof synaptic plasticity,wecomparedsynaptic scaling inb3/
and b3+/ neurons in dissociated cultures and in slice cultures,
a preparation that largely retains the native hippocampal circuitry.
In bothpreparations, TTX treatment scaledmEPSCs in b3+/ neu-
rons toasimilar extentaswasobserved in ratcultures. Incontrast,
scaling was prevented in b3/ cultures (Figures 8G and 8H). Al-
together, these results demonstrate that b3 integrins are required
for homeostatic synaptic scaling induced by activity deprivation.
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Previous studies using RGD peptides have demonstrated that
synaptic transmission and ion channels can be influenced by in-
tegrins on a rapid timescale. For example, at the neuromuscular
junction, integrins modulate neurotransmitter release induced by
muscle stretch by directly translating mechanical changes in
membrane tension across the synaptic cleft (Chen and Grinnell,
1995; Chen and Grinnell, 1997). Furthermore, RGD peptides
affect the activity of high-voltage-activated Ca2+ channels within
minutes (Wildering et al., 2002; Wu et al., 1998). In our experi-
ments, echistatin increased dynamin-dependent GluR2 endocy-
tosis also within minutes, leading to a reduction in synaptic
AMPAR currents. It is unlikely that the effect was a consequence
of a generalized increase in endocytosis, as it was specific to
GluR2 over GluR1, and NMDAR currents were not affected.
Given that AMPAR endocytosis likely occurs mainly at extrasy-
naptic sites (Ashby et al., 2004; Blanpied et al., 2002), integrin-
mediated cell adhesion may gate the lateral diffusion of GluR2-
containing AMPARs between synaptic sites and extrasynaptic
endocytic hotspots. Alternatively, the increase in GluR2 endocy-
tosis may be due to a modification in integrin-dependent signal-
ing that directly converges on the endocytic machinery.
As previously reported for AMPA-, NMDA-, and insulin-in-
duced AMPAR internalization (Beattie et al., 2000; Carroll et al.,
1999; Ehlers, 2000; Lin et al., 2000; Lissin et al., 1999; Man
et al., 2000), GluR2 endocytosis induced by echistatin required
the elevation of intracellular Ca2+. Moreover, echistatin activated
the small GTPase Rap1, and active Rap1 was necessary for the
reduction in AMPAR currents. While these observations are con-
sistent with the reported involvement of Rap1 in AMPAR traffick-
ing (Fu et al., 2007; Thomas and Huganir, 2004; Zhu et al., 2002)
and the requirement of NMDARs and intracellular Ca2+ elevation
for Rap1 activation (Franke et al., 1997; Kennedy et al., 2005; Xie
et al., 2005), our findings identify a link between integrin signaling
and Rap1-dependent regulation of AMPAR trafficking. Notably,
while basal NMDAR activity was necessary for the echistatin-
induced decrease in AMPAR currents, probably as a source of
Ca2+, echistatin application by itself did not alter NMDAR cur-
rents. It is therefore likely that integrin- and NMDAR-dependent
signaling pathways converge on Rap1 to exert joint control on
AMPARs.
How do the effects of acute pharmacological treatments relate
with those of chronic manipulations of b3 integrin expression? At
least part of the mechanisms appears to be shared because
echistatin required functional postsynaptic b3 integrins in order
to reduce synaptic AMPAR currents. Moreover, both acute
RGD peptide application and chronic expression of b3 integrin
constructs affected quantal size by preferentially targeting
GluR2-containing AMPARs (Figure S10). Previous work has
shown that PICK1, which binds to the GluR2 C terminus and
PKC, also controls the GluR2 content of synaptic AMPARs
(Terashima et al., 2004). It will be of interest to see whether
PICK and PKC are involved in mediating the effects b3 integrins
on synaptic AMPAR currents.
Surprisingly, echistatin-mediated reduction of mEPSC ampli-
tude was not dependent on the polymerization state of actin.
Moreover, neither echistatin application nor overexpression ofb3 integrins significantly affected dendrite and spine morphol-
ogy. Application of short synthetic RGD peptides at high doses
has been reported to both lengthen and shorten dendritic protru-
sions (Bourgin et al., 2007; Shi and Ethell, 2006). Because, at the
concentrations used in the above studies, RGD peptides may
have integrin-independent effects (Figure S2; Buckley et al.,
1999), the results based on high concentrations of short syn-
thetic RGD peptides should be interpreted with caution. Studies
in which various integrin subunits were genetically ablated also
reported no effect on neuronal or synaptic structure (Chan
et al., 2003, 2006; Grotewiel et al., 1998; Huang et al., 2006;
but seeRohrbough et al., 2000).While our data indicate a specific
role for b3 integrins in regulating synaptic AMPARs indepen-
dently of postsynaptic structure, other integrin subtypes may
be involved in spine morphogenesis (cf. Webb et al., 2007).
We find that integrins are critical for homeostatic synaptic
plasticity, a previously unrecognized function for this class of
cell adhesion molecules in the CNS. In particular, our experi-
ments point to a specific role for b3 integrins. Whereas exoge-
nous expression of b3 integrins was sufficient to scale synaptic
AMPAR currents, chronic modification of network activity also
altered surface expression of endogenous b3. Importantly, TTX
was ineffective in scaling synaptic AMPAR currents when b3
integrins were genetically ablated, demonstrating their require-
ment for this form of synaptic plasticity.
Although expression of synaptic scaling is thought to be
caused, at least in part, by changes in the abundance and com-
position of AMPARs, themolecular mechanisms involved are still
poorly understood (Davis, 2006). Furthermore, different induction
protocols for homeostatic plasticity may achieve scaling by
targeting different AMPAR subunits (Ju et al., 2004; Thiagarajan
et al., 2005; Wierenga et al., 2005). For instance, a recent report
demonstrated that homeostatic synaptic scaling, similarly to
LTP, involves a transient incorporation of GluR2-lacking
AMPARs, which are subsequently replaced by GluR2-containing
receptors (Plant et al., 2006; Sutton et al., 2006; but see Adesnik
and Nicoll, 2007). Without this exchange in subunit composition,
the increase in synaptic strength would eventually decline.
Among potential molecular mediators of homeostatic synaptic
plasticity, the activity-dependent release of a cytokine, TNFa,
fromglial cells hasbeen shown to be critical for TTX-induced syn-
aptic scaling (Stellwagen and Malenka, 2006). Our study iden-
tifies a role for b3 integrins in TNFa-dependent synaptic scaling.
Notably, in nonneuronal cells, exposure to TNFa augments aVb3
integrin levels (Gao et al., 2002; Hynes, 2002). Similarly, in neu-
rons, we find that acute treatment with TNFa increases surface
b3 expression nearly as much as chronic incubation with TTX.
As previously shown (Stellwagen et al., 2005), we noticed that
acute application of TNFa induced a modest increase in GluR2
surface levels (18%). However, prolonged treatment with
TNFa (12 hr) augmentedGluR2 surface expressionmore robustly
(34%, Figure 8F). The progressive accumulation of glial TNFa in
the extracellular medium in response to activity deprivation may
therefore control synaptic scaling by first increasing GluR1 ex-
pression (Stellwagen et al., 2005; Stellwagen and Malenka,
2006) and subsequently upregulating GluR2 levels on a longer
timescale and in an integrin-dependent manner. In this way,
TTX-induced synaptic scaling will eventually result in an increaseNeuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc. 759
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(Wierenga et al., 2005). We thus propose that postsynaptic b3 in-
tegrins are specifically involved in the late GluR2-dependent
phase of homeostatic synaptic scaling that is necessary to main-
tain enhanced synaptic strength.
In summary, our findings are consistent with a model in which
b3 integrins function as a negative-feedback regulator of synap-
tic strength. Synaptic AMPARs are effectively stabilized by b3
integrins, whereas loss or lack of contact with b3 extracellular
ligands is associated with a reduction in AMPAR content. We
propose that synapses exploit the state of b3 integrin interac-
tions with their extracellular ligands to fine tune AMPAR currents
according to the level of neuronal network activity (Figure S10).
Trans-synaptic interactions between pre- and postsynaptic cell
adhesion molecules, for example between postsynaptic b3
integrins and presynaptic L1 or semaphorin proteins (Blaess
et al., 1998; Pasterkamp et al., 2003), would provide the most
direct way to detect changes in presynaptic activity. However,
equally important roles might be played by indirect interactions
across the synaptic cleft and between neurons and glial cells
via extracellular matrix proteins and the integrins that interact
with them.
EXPERIMENTAL PROCEDURES
Detailed methods are described in Supplemental Experimental Procedures.
Neuronal Cultures and Transfection
Dissociated and slice hippocampal cultures were prepared as previously
described (De Simoni et al., 2003; Morales et al., 2000). Dissociated rat hippo-
campal cultures were transfected at 8–12 DIV using aCa2+ phosphate protocol
(Xia et al., 1996) and used for experiments after 1–3 days. For transmembrane
proteins, surface expression of the constructs was confirmed by live labeling
with antibodies against extracellular epitopes.
Electrophysiology
Whole-cell recordings were performed from pyramidal neurons of dissociated
hippocampal cultures and CA1 pyramidal neurons of mouse slice cultures as
previously described (De Simoni et al., 2003; Morales et al., 2000). Recordings
from experimental and control cells were interleaved, and sister cultures were
used between groups. Each set of experiments was performed on at least two
independent cultures.
Imaging
Internalization of endogenous GluR1 and GluR2 was determined using an
antibody-feeding assay as previously described (Passafaro et al., 2001). Con-
focal images were analyzed blindly to the experimental condition using ImageJ
(NIH). For each channel, dendritic regions were separately thresholded based
on the gray level histogram of a neuron-free area in the same field of view
(mode plus three times the standard deviation). The ratio between the thresh-
olded dendritic fluorescence of the red channel and the sum of the values for
green and red channels was defined as ‘‘internalized fraction.’’ Surface
expression of GluR1, GluR2, b1, b3, CTb1, and CTb3 was evaluated by live
labeling. For untransfected neurons, analysis was performed on the full field
of view; for transfected cells, only the fluorescence signal colocalizing with
the GFP or mRFP counterstains was considered. Images were thresholded
as above. Spine analysis was carried out according to De Simoni et al.
(2003). Controls were always performed in parallel on sister cultures.
Rap1 Activation Assay
Activation of endogenous Rap1 in neurons was examined using the EZ-Detect
Rap1 Activation Kit (Pierce, Rockford, IL) according to the manufacturer’s
instructions.760 Neuron 58, 749–762, June 12, 2008 ª2008 Elsevier Inc.Statistical Analysis
For normally distributed data (normality determined by the one-sample Kolmo-
gorov-Smirnov test), statistical differences were assessed using the paired
and unpaired two-tailed Student’s t test as required. The Mann-Whitney test
was used when the criteria for normality were not met, and the two-sample
Kolmogorov-Smirnov test was applied to mEPSC amplitude distributions
(Igor Pro 4.07; Instat 3, GraphPad Software Inc., San Diego, CA). In figures,
statistical significance is indicated by (*) for 0.05 < p < 0.01, (**) for 0.01 < p <
0.001, and (***) for p < 0.001. Average data are expressed as mean ± SEM.
SUPPLEMENTAL DATA
The Supplemental Data for this article, including Supplemental Experimental
Procedures and Figures, can be found online at http://www.neuron.org/cgi/
content/full/58/5/749/DC1/.
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